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I left the Centers for Disease Control and Prevention 
(CDC) more than 4 years ago to go to the Robert Wood 
Johnson Foundation (RWJF). RWJF had gone through a 
time of substantial rethinking about its role in society and 
come to the conclusion that the focus should not be grant-
making; it should be creating social change for health. This 
could just as easily be said about public health — creating 
societal change to improve the health of the public.
 
At its core, public policy is the way a society frames what 
it wishes to become. Does it want all children immunized? 
Does it want to limit the use of tobacco? Policy doesn’t have 
to be federal legislation or regulation; it can be corporate 
or local or state. But an organization, a field, or groups 
that are about social change will find they are often about 
influencing public policy.
 
How does this fit with epidemiology and its history, and 
the history of CDC?
 
It is unlikely that John Snow would be revered in pub-
lic health if he had merely studied cholera. His defining 
moment was when he removed the pump handle from the 
contaminated well that was the source of the epidemic. 
That  intervention  is  honored  with  an  award  called  the 
Pump Handle Award that is given by the Council of State 
and  Territorial  Epidemiologists.  Our  heroes  have  been 
tied to action.
 
In 1983, giving the Wade Hampton Frost Lecture at the 
American Public Health Association meeting, Bill Foege, 
former CDC director, coined the term consequential epi-
demiology. Foege was taking sides in an active debate of 
the time by saying that epidemiology “is a tool to change 
the world, not merely to study the world” (unpublished 
material, 1983). The debate that Foege was speaking to 
was whether epidemiologists should engage in the political 
process. Should they advocate solutions about what should 
happen based on the science or merely do the science and 
let the advocates and policy makers use the science? Some 
people said that scientists would lose their objectivity if 
they took on this more activist role. This discussion has 
come back, quite strongly, in recent times in the context of 
the politicization of science. Politics and public policy can 
be tough business, especially recently.
 
Bill Foege was of a very different opinion. It was his 
conviction that public health was inherently political, ines-
capably political. Foege argued that public health work 
occurs in a political context and that, divorced from that 
context, our science is stillborn, a missed opportunity. To 
pretend otherwise is self-delusion and a failure of vision 
and responsibility.
 
The  purpose  of  this  essay  is  to  reaffirm  that  connec-
tion to activism. I state this not despite recent concerns 
about  politicization  of  science  but  because  of  them.  We 
must embrace both 1) activism and commitment to social 
change as central to public health, and 2) the central pur-
pose of epidemiologic science, which is to find, assess, and 
confirm truth, regardless of past findings or beliefs. These 
are different roles, and the space between them is where 
the  real  excitement  is.  Actions  are  being  taken  based 
on the science as it is known today, but the actions will 
change as the science advances.
 
We are entering a period of economic pressure that is 
likely  to  change  the  nature  of  America’s  medical  care, 
the largest industry in our nation. We now spend about 
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twice  as  much  as  other  developed  countries  per  capita 
per year. Despite the importance of biological science as 
the basis for improvements in diagnosis and therapy, it is 
impossible to think of major changes in the medical care 
system that will not play out in public policy changes. The 
public’s health and the societal factors that affect health 
span a much greater proportion of our economy and our 
society than even medical care does. This means that pub-
lic health will have to address issues that have political 
implications. Yet the science behind what can be done does 
not mean it will be done.
 
Our policy makers and the public have not been nearly 
as committed to the understanding that how our society 
is organized, what our policies foster or inhibit, what our 
communities encourage and our institutions support are 
fundamental causes of good or ill health, just like biologi-
cal causes, and they warrant study and action. If societal 
forces are not in alignment, scientific advances stall, and 
the  value  realized  is  a  meager  fraction  of  its  potential. 
Scientific  understanding  about  any  disease  that  is  not 
widely  applied  to  people  in  need  is  ultimately  wasted. 
Similarly, widespread application of practices and policies 
that have no scientific evidence of effectiveness are just 
as futile. Scientific discovery and widespread application 
must never be separated.
 
This  is  a  defining  tension  for  all  of  public  health. 
Scientists never feel they know enough to act. Practitioners 
and activists say the health problems are so significant we 
must act now; we can’t wait for the science to be final-
ized. Both are right. Organizations only responsible for 
research will worry less about whether the findings are 
widely applied or are feasible and practical. Organizations 
only responsible for programs will likely hold to outmoded 
ways that are ineffective if their staff and clients like the 
program.  Managed  well,  the  combined  responsibilities 
make both science and program better.
Role of Epidemiologic Science
 
Most people think only about the biologic mechanisms 
as the fundamental causes of good or ill health, hence of 
medical care as the central intervention for health. What 
many people fail to realize is that the likelihood of initially 
developing a disease or being injured has little to do with 
access to the medical care system. This is especially true 
regarding population differences. Initially developing an 
illness or suffering an injury is more related to such things 
as whether people smoke, what and how much they eat, 
how  active  they  are,  what  toxins  or  microbes  they  are 
exposed to, and whether their neighborhood or worksite 
is safe.
 
The Tao Te Ching, an ancient Chinese text about how 
society operates, says that the leader should guide quietly 
and  unobtrusively  so  that  the  decisions  that  are  made 
are felt by the people to be ones they came to. If a leader 
aggressively  pushes  decisions,  those  will  be  met  with 
strong  opposition.  Epidemiologists’  place  in  society  can 
be very much like that of the Taoist leader: a position of 
tremendous power and influence, but only if it is guided 
carefully and not forced.
 
More than any other group in health, epidemiologists 
decide  how  to  measure  the  health  of  the  nation.  They 
choose what questions are asked and analyzed, what dif-
ferences are important, serious, and worthy of comment, 
even  alarm.  If  you  do  not  ask  the  questions,  the  only 
answer is silence.
 
It is a position of huge responsibility and equally large 
opportunity to profoundly affect the national debate about 
health. At its most powerful, epidemiology is about asking 
questions of the most fundamental but often hard to mea-
sure, aspects of health, wellness, and even happiness and 
life satisfaction that comprise the fullness of the World 
Health  Organization  definition  of  health.  When  framed 
in the context of disparity, it opens up how that vision 
of health ties to our nation’s highest ideals of equality of 
opportunity.
 
Also powerful is how the epidemiologist frames findings. 
Articles  published  during  the  early  stages  of  the  obe-
sity epidemic got little attention, even though the upward 
trend was clear. In the late 1990s Ali Mokdad, a CDC sci-
entist who was then running the Behavioral Risk Factor 
Surveillance System (BRFSS), had the idea to use maps, 
which have become well known in the field, to illustrate 
the change in obesity in the nation.
 
A series of color-coded maps showed changes in obe-
sity rates over the years in each US state. The rapidity 
of the increases, coupled with geographic framing, was 
a  visually  powerful  representation  of  the  increase  in 
prevalence. Those images, probably more than any other, 
caused the media and the public to take notice. That art VOLUME 6: NO. 4
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to frame and energize debate often goes unrecognized, 
but it is another lever that epidemiologists have — the 
power of display and presentation and framing as leading 
without forcing.
 
Lastly, epidemiology plays a role in evaluating the effect 
of policies implemented. This study of policy is often a very 
tricky issue. Frequently, conducting a randomized trial is 
nearly impossible in public policy, where nonrandom natu-
ral experiments are sometimes the best possible evidence. 
Societal decisions often have to be made on the basis of 
evidence that is not as controllable as a randomized trial 
of medication effectiveness. The role of epidemiology is to 
be that honest broker of the science, regularly improving 
understanding and identifying problems and risks.
 
Public  health  practice  and  public  policy  are  about 
applying what is known and possible. It is much like an 
oncologist may treat a cancer patient, knowing that the 
treatment has great limitations and that new science will 
come, but he must act now to help the patient using what 
is available. The public health practitioner must act on 
behalf of the people and must be prepared to change course 
as the science improves. This means that epidemiologists 
must be free to speak about their findings, and they must 
be true to what the data show. Public health and the rest 
of the public process, including policy, will use those find-
ings, more or less within a societal and political context.
 
To return to the cholera story, it turns out that John 
Snow did not actually remove the pump handle from the 
well. Steven Johnson, in his excellent history of the cholera 
epidemic, The Ghost Map (1), writes that on September 7, 
1854, John Snow presented his findings to the board of 
governors  of  St.  James  Parish.  After  much  discussion, 
the board voted to close the Broad Street well, despite its 
reputation for clean water, because the evidence was so 
strong. Snow’s place of honor in our field is thus even more 
warranted  as  an  early  interplay  between  epidemiologic 
science, public policy, and health. At its best, epidemiology 
is persuasive.
Why Public Health and Prevention?
 
During the past decade we have added approximately 
$1 trillion annually to our medical care budget and lost 
ground in life expectancy and infant mortality relative to 
other countries of similar economic development. Simply 
put, they are getting healthier, faster than we are, despite 
our great increase in funds. Health care reform is essen-
tial, but as a nation we will have to embrace other ways 
to improve health and to rein in the rate of increase in the 
growth in medical care costs. Public health and prevention 
should be part of that solution.
 
Public health practitioners tend to think of health as the 
outcome that people want, so we talk about the importance 
of getting a flu shot or not smoking to prevent illness or 
death. But what do people really seek when they aspire 
to a healthier life? I believe that what people really want 
is a meaningful, satisfying life of doing things they value 
and enjoy.
 
Good health is not the end but the means to an end. 
Health is a crucial foundation on which people have their 
best chance to build an enjoyable and satisfying life for 
themselves  and  their  families.  The  political  will  of  our 
leaders is often built the same way, as are the priorities 
of business and industry. As political leaders think about 
major program or policy needs, they think about what is 
most important for their state or city. Usually that is about 
helping it become economically stronger, a better place for 
families to live, work, and play. For those leaders, recog-
nizing that health is a means to these ends and a measure 
of how good a place is to raise a family helps connect it to 
the things they find valuable.
Social Justice
 
We need to work harder to achieve social justice. The phi-
losophy of public health is social justice. Our responsibility 
is to do what we can to reduce or eliminate disparity.
 
In 1986 Bill Foege spoke against the backdrop of circum-
stances that were not all that different from our own: an 
economy just coming out of recession, ballooning deficits, 
and malfunctioning markets. He said:
 
. . . because of the way the market system works, 
our  special  clientele  .  .  .  will  continue  to  be  the 
poor, the homeless, the unimmunized, the hungry, 
the addicted, and those who simply find the sys-
tem overwhelming. . . . Let me assure you, we will 
survive any crisis that involves funding, political 
support, popularity, or cyclic trends, but we can’t 
survive the internal crisis, if we become provincial, VOLUME 6: NO. 4
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focus totally on the short term, or if we lose our 
philosophy of social justice (2).
 My final challenge, a challenge that only our nation’s 
practicing  public  health  epidemiologists  can  accept,  is 
to report injustice and disparity regardless of your field 
of study. Public health’s overarching goal is to reduce or 
eliminate differences in health and, ultimately, what gets 
measured is what gets done. That means you must mea-
sure — justice.
Acknowledgments
 
This  manuscript  was  adapted  from  the  Alexander  D. 
Langmuir Lecture given at the 2009 Epidemic Intelligence 
Service  Conference  in  Atlanta,  Georgia,  on  April  22, 
2009.
Author Information
 
James S. Marks, MD, MPH, Senior Vice President, The 
Robert Wood Johnson Foundation, PO Box 2316, Route 1 
and College Rd E, Princeton, NJ 08543. Telephone: 609-
627-5796. E-mail: jmarks@rwjf.org.
References
1.  Johnson S. The ghost map. New York: Penguin Group; 
2006.
2.  Foege WH. Public health: moving from debt to legacy. 
Am J Public Health 1987;77(10):1276-8.